Expand FEMY Menu
FEMY MENU

FEMY Latest Press Releases

-- February 3, 2026 --

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products Globe Newswire 9:15 AM

-- January 14, 2026 --

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement Globe Newswire 9:00 AM

-- January 13, 2026 --

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed in Community-Based Care Globe Newswire 9:00 AM

-- December 18, 2025 --

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device Globe Newswire 9:15 AM

-- November 25, 2025 --

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment Business Wire 9:15 AM

-- November 10, 2025 --

Femasys Advances Global Growth with Second Partner Order for FemBloc in Europe Globe Newswire 9:00 AM

-- November 3, 2025 --

Femasys Secures FDA Approval to Advance Final FemBloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million Globe Newswire 8:30 AM

-- October 22, 2025 --

Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc Permanent Birth Control in Europe Globe Newswire 9:00 AM

-- October 16, 2025 --

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo Globe Newswire 9:00 AM

-- September 25, 2025 --

Femasys Accelerates European Growth for FemBloc with Kebomed Partnership Globe Newswire 9:00 AM

-- September 22, 2025 --

Femasys Partners with Medical Electronic Systems to Launch FemSperm Analysis Kit for use with FemaSeed Globe Newswire 9:00 AM

-- September 11, 2025 --

Femasys Expands FemSperm Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes